← Open Payments lookup

TATEVIK MIKAELYAN: Open Payments

NPI 1881095925 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,033 in 143 payments from 20 companies in 2025. Trend: 2023 $2,161 · 2024 $2,460 · 2025 $3,033

Food & beverage: $3,032Education: $1
CompanyPaymentsAmount
ABBVIE INC.26$483
Axsome Therapeutics, Inc.17$398
AstraZeneca Pharmaceuticals LP14$381
Takeda Pharmaceuticals U.S.A., Inc.17$337
Novo Nordisk Inc13$306
Lundbeck LLC12$228
PFIZER INC.10$176
Otsuka America Pharmaceutical, Inc.8$170
Lilly USA, LLC6$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$103

Products named: REXULTI, TRINTELLIX, QULIPTA, Symbravo, VRAYLAR, Auvelity, AIRSUPRA, UBRELVY.

Industry payments across MD — which companies pay providers there.